ВЕТРЯНАЯ ОСПА И ОПОЯСЫВАЮЩИЙ АИШАЙ: ОСОБЕННОСТИ ЗАБОЛЕВАЕМОСТИ И КЛИНИЧЕСКИХ ПРОЯВЛЕНИЙ


Цитировать

Полный текст

Аннотация

В обзоре систематизированы данные о патогенезе и клинических проявлениях первичной VZV-инфекции и инфекции вследствие реактивации вируса. Рассмотрены особенности течения ветряной оспы у беременных и новорожденных, обобщены данные о неврологических, офтальмологических и висцеральных осложнениях этих инфекций. Особое внимание уделено эпидемиологии и патогенезу тяжелого осложнения VZV-инфекции в виде VZV-васкулопатии. Кроме типичных форм, упоминается о стертой форме инфекции при реактивации VZV, протекающей без характерных высыпаний на коже и слизистых, - zoster sine herpete. Впервые в русскоязычной литературе сообщается о субклинической форме инфекции при реактивации вируса ветряной оспы.

Полный текст

Доступ закрыт

Об авторах

Вячеслав Федорович ЛАВРОВ

НИИ вакцин и сывороток им. И.И.Мечникова РАМН, Москва

Email: mech.inst@mail.ru
д-р мед. наук, проф., рук. лаб.диагностики вирусных инфекций

Александра Сергеевна КАЗАНОВА

НИИ вакцин и сывороток им. И.И.Мечникова РАМН, Москва

мл. науч. сотр. лаб. диагностики вирусных инфекций

Станислав Николаевич КУЗИН

НИИ вакцин и сывороток им. И.И.Мечникова РАМН, Москва

д-р мед. наук., проф., вед. науч. сотр. лаб. диагностики вирусных инфекций

Дмитрий Васильевич ДУБОДЕЛОВ

Главный центр санитарно-эпидемиологического надзора внутренних войск МВД России

зав. организационно-методическим отделом

Список литературы

  1. Kilgore P.E., Kruszon-Moran D., Seward J.F. Varicella in Americans from NHANES III: implications for control through routine immunization. J. Med. Virol. 2003; 70 (Suppl. 1): S111-S118.
  2. Roush S.W., Murphy T.V. Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. J.A.M.A. 2007; 298(18): 2155-2163.
  3. Gershon A.A., Chen J., Gershon M.D. A model of lytic, latent, and reactivating varicella-zoster virus infections in isolated enteric neurons. J. Infect. Dis. 2008; 197 (Suppl. 2): S61- S65.
  4. Banz K., Wagenpfeil S., Neiss A. The burden of varicella in Germany. Potential risks and economic impact. Eur. J. Hlth Econ. 2004; 5(1): 46-53.
  5. Moffat J.F., Stein M.D ., Kaneshima H. Tropism of Varicella-zoster virus to human CD 4+ and CD8+ T-lymphocytes and epidermal cells in SCID-hu mice. J. Virol. 1995; 69: 5236-5240.
  6. Whitley R.J. Therapeutic approaches to varicella-zoster virus infections. J. Infect. Dis. 1992; 166 (Suppl. 1): S51-S57.
  7. Arvin A.M. Varicella-zoster virus: overview and clinical manifestations. Semin. Dermatol. 1996; 15 (Suppl. 1): 4 -7.
  8. Mohsen A.H., McKendrick M. Varicella pneumonia in adults. Eur. Respir. J. 2003; 21(5): 886-891.
  9. Chiner E., Ballester I., Betlloch I. Varicella-zoster virus pneumonia in an adult population: has mortality decreased? Scand. J. Infect. Dis. 2010; 42(3): 215-221.
  10. Heininger U., Seward J.F. Varicella. Lancet. 2006; 368(9544): 1365-1376.
  11. Guess H.A., Broughton D.D., Melton L.J. 3rd. Population-based studies of varicella complications. Pediatrics. 1986; 78 (Pt 2): 723-727.
  12. Dangond F., Engle E., Yessayan L. Pre-eruptive varicella cerebellitis confirmed by PCR. Pediat. Neurol. 1993; 9(6): 491-493.
  13. Johnson R., Milbourn P.E. Central nervous system manifestations of chickenpox. Can. Med. Assoc. J. 1970; 102(8): 831-834.
  14. Jellinek E.H., Tulloch W.S. Herpes zoster with dysfunction of bladder and anus. Lancet. 1976; 2(7997): 1219-1222.
  15. Enders G., Miller E., Cradock-Watson J. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994; 343(8912): 1548-1551.
  16. Higa K., Dan K., Manabe H. Varicella-zoster virus infections during pregnancy: hypothesis concerning the mechanisms of congenital malformations. Obstet. Gynecol. 1987; 69(2): 214-222.
  17. Rodríguez-Fanjul X., Noguera A., Vicente A. Herpes zoster in healthy infants and toddlers after perinatal exposure to varicella-zoster virus: a case series and review of the literature. Pediat. Infect. Dis. J. 2010; 29(6): 574-576.
  18. Gold I., Azizi E., Eshel G. Neurogenic bladder due to herpes zoster infection in an infant. Eur. J. Pediat. 1989; 148(5): 468-469.
  19. Smith C.K., Arvin A.M. Varicella in the fetus and newborn. Semin. Fetal. Neonatal. Med. 2009; 14(4): 209-217.
  20. Liedtke W., Opalka B., Zimmermann C.W. Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue. J. Neurol. Sci. 1993; 116: 6-11.
  21. Cohrs R.J., Randall J., Smith J. Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using realtime PCR. J. Virol. 2000; 74: 11464-11471.
  22. Hufner K., Derfuss T., Herberger S. Latency of alpha-herpes viruses is accompanied by a chronic inflammation in human trigeminal ganglia but not in dorsal root ganglia. J. Neuropathol. Exp. Neurol. 2006; 65: 1022-1030.
  23. Inoue H., Motani-Saitoh H., Sakurada K. Detection of varicella-zoster virus DNA in 414 human trigeminal ganglia from cadavers by the polymerase chain reaction: a comparison of the detection rate of varicella-zoster virus and herpes simplex virus type 1. J. Med. Virol. 2010; 82: 345-349.
  24. Hicks L.D., Cook-Norris R.H., Mendoza N. Family history as a risk factor for herpes zoster: a case-control study. Arch. Dermatol. 2008; 144(5): 603-608.
  25. Harpaz R., Ortega-Sanchez I.R., Seward J.F. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2008; 57(RR-5): 1-30.
  26. Insinga R.P., Itzler R.F., Pellissier J.M. The incidence of herpes zoster in a United States administrative database. J. Gen. Intern. Med. 2005; 20(8): 748-753.
  27. Patterson-Bartlett J., Levin M.J., Lang N. Phenotypic and functional characterization of ex vivo T cell responses to the liveattenuated herpes zoster vaccine. Vaccine 2007; 25: 7087-7093.
  28. Oxman M.N., Levin M.J., Johnson G.R. Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. New Engl. J. Med. 2005; 352(22): 2271-2284.
  29. Liesegang T.J. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology 2008; 115(Suppl. 2): S3- S12.
  30. Taguchi T., Ueda S., Kudo T. Ramsay-Hunt syndrome. J. Infect. 2010; 23.
  31. Shim H.J., Jung H., Park D.C. Ramsay Hunt syndrome with multicranial nerve involvement. Acta Otolaryngol. 2011; 131(2): 210-215.
  32. Mendieta C., Miranda J., Brunet L.I. A lveol a r bone necrosis and tooth exfoliation following herpes zoster infection: a review of the literature and case report. J. Periodontol. 2005; 76(1): 148-153.
  33. Volvoikar P., Patil S., Dinkar A. Tooth exfoliation, osteonecrosis and neuralgia following herpes zoster of trigeminal nerve. Indian J. Dent. Res. 2002 ; 13(1): 11-14.
  34. Gilden D.H., Gesser R., Smith J. Presence of VZV and HSV-1 DNA in human nodose and celiac ganglia. Virus Genes. 2001; 23(2): 145-147.
  35. Linnemann C.C.Jr., Alvira M.M. Pathogenesis of varicella-zoster angiitis in the CNS. Arch. Neurol. 1980; 37(4): 239-240.
  36. Devinsky O., Cho E.S., Petito C.K. Herpes zoster myelitis. Brain 1991; 114 (Pt 3): 1181-1196.
  37. Gilden D.H. Varicella zoster virus vasculopathy and disseminated encephalomyelitis. J. Neurol. Sci. 2002; 195(2): 99-101.
  38. Watson C.P., Deck J.H., Morshead C. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 1991; 44(2): 105-117.
  39. Gilden D.H., Wright R.R., Schneck S.A. Zostersineherpete, a clinical variant. Ann. Neurol. 1994; 35(5): 530-533.
  40. Harpaz R., Ortega-Sanchez I.R., Seward J.F. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2008; 57(RR-5): 1-30.
  41. Gauthier A., Breuer J., Carrington D. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol. Infect. 2009; 137(1): 38-47.
  42. Drolet M., Brisson M., Schmader K. Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study. J. Pain. 2010; 11(11): 1211-1221.
  43. Thomas J.E., Howard F.M. Jr. Segmental zoster paresis a disease profile. Neurology 1972; 22(5): 459-466.
  44. Gilden D.H., Beinlich B.R., Rubinstien E.M. Varicellazoster virus myelitis: an expanding spectrum. Neurology 1994; 44(10): 1818-1823.
  45. Gilden D.H., Kleinschmidt-DeMasters B.K., Wellish M. Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5-1995 revisited. Neurology 1996; 47(6): 1441-1446.
  46. Mayberg M.R., Zervas N.T., Moscowitz M.A. Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry. J. Comp. Neurol. 1984; 223: 46-56.
  47. Gilden D., Mahalingam R., Nagel M.A. Review: The neurobiology of varicella zoster virus infection. Neuropathol. Appl. Neurobiol. 2011. doi: 0.1111/j.1365-2990.2011.01167.x.
  48. Mayberg M., Langer R.S., Zervas N.T. Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headaches in man. Science 1981; 213(4504): 228-230.
  49. Saito K., Moskowitz M.A. Contributions from the upper cervical dorsal roots and trigeminal ganglia to the feline circle of Willis. Stroke 1989; 20(4): 524-526.
  50. Gilden D.H., Kleinschmidt-DeMasters B.K., LaGuardia J.J. Neurologic complications of the reactivation of varicellazoster virus. New Engl. J. Med. 2000; 342(9): 635-645.
  51. Gilden D.H. Varicella zoster virus vasculopathy and disseminated encephalomyelitis. J. Neurol. Sci. 2002; 195(2): 99-101.
  52. Gray F., Bélec L., Lescs M.C. Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain 1994; 117 (Pt 5): 987-999.
  53. Katchanov J., Siebert E., Klingebiel R. Infectious vasculopathy of intracranial large- and medium-sized vessels in neurological intensive care unit: a clinico-radiological study. Neurocrit Care. 2010; 12(3): 369-374.
  54. Lin H.C., Chien C.W., Ho J.D. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology 2010; 74(10): 792-797.
  55. Amlie-Lefond C., Jubelt B. Neurologic manifestations of varicella zoster virus infections. Curr. Neurol. Neurosci Rep. 2009; 9(6): 430-434.
  56. Askalan R., Laughlin S., Mayank S. Chickenpox and stroke in childhood: a study of frequency and causation. Stroke 2001; 32(6): 1257-1262.
  57. Braun K.P., Bulder M.M., Chabrier S. The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Brain 2009; 132(Pt 2): 54 4 -557.
  58. Askalan R., Laughlin S., Mayank S. Chickenpox and stroke in childhood: a study of frequency and causation. Stroke 2001; 32(6): 1257-1262.
  59. Holland G.N. The progressive outer retinal necrosis syndrome. Int. Ophthalmol. 1994; 18(3): 163-165.
  60. Soushi S., Ozawa H., Matsuhashi M. Demonstration of varicella-zoster virus antigens in the vitreous aspirates of patients with acute retinal necrosis syndrome. Ophthalmology 1988; 95(10): 1394-1398.
  61. Tan J.C.H., Byles D., Stanford M.R. Acute retinal necrosis in children caused by herpes simplex virus. Retina 2001; 21(4): 344-347.
  62. Thompson W.S., Culbertson W.W., Smiddy W.E. Acute retinal necrosis caused by reactivation of herpes simplex virus type 2. Amer. J. Ophthalmol. 1994; 118(2): 205-211.
  63. Engstrom R.E.Jr., Holland G.N., Margolis T.P. The progressive outer retinal necrosis syndrome. A variant of necrotizing herpetic retinopathy in patients with AIDS. Ophthalmology 1994; 101(9): 1488-1502.
  64. Guex-Crosier Y., Rochat C., Herbort C.P. Necrotizing herpetic retinopathies. A spectrum of herpes virus-induced diseases determined by the immune state of the host. Ocul. Immunol. Inflamm. 1997; 5(4): 259-265.
  65. Lewis J.M., Nagae Y., Tano Y. Progressive outer retinal necrosis after bone marrow transplantation. Amer. J. Ophthalmol. 1996; 122(6): 892-895.
  66. Franco-Paredes C., Bellehemeur T., Merchant A. Aseptic meningitis and optic neuritis preceding varicella-zoster progressive outer retinal necrosis in a patient with AIDS. AIDS 2002; 16(7): 1045-1049.
  67. Menerath J.M., Gerard M., Laurichesse H. Bilateral acute retinal necrosis in a patient with acquired immunodeficiency syndrome. J. Ophthalmol. 1995; 18: 625-633.
  68. Mehta S.K., Cohrs R.J., Forghani B. Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J. Med. Virol. 2004; 72(1): 174-179.
  69. Schünemann S., Mainka C., Wolff M.H. Subclinical reactivation of varicella-zoster virus in immunocompromised and immunocompetent individuals. Intervirology 1998; 41(2-3): 98-102.
  70. Cinque P., Bossolasco S., Vago L. Varicella-zoster virus (VZV) DNA in cerebrospinal fluid of patients infected with human immunodeficiency virus: VZV disease of the central nervous system or subclinical reactivation of VZV infection? Clin. Infect. Dis. 1997; 25(3): 634-639.
  71. Terada K., Kawano S., Yoshihiro K. Varicella-zoster virus (VZV) reactivation is related to the low response of VZV-specific immunity after chickenpox in infancy. J. Infect. Dis. 1994; 169(3): 650-652.
  72. Birlea M., Arendt G., Orhan E. Subclinical reactivation of varicella zoster virus in all stages of HIV infection. J. Neurol. Sci. 2011. [Epub ahead of print].
  73. Mahalingam R., Traina-Dorge V., Wellish M. Simian varicella virus reactivation in cynomolgus monkeys. Virology 2007; 368(1): 50-59.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ООО «Бионика Медиа», 2011